0000103145false00001031452023-11-062023-11-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): November 6, 2023

VEECO INSTRUMENTS INC.

(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction
of incorporation)

0-16244
(Commission
File Number)

11-2989601
(IRS Employer
Identification No.)

Terminal Drive, Plainview, New York 11803

(Address of principal executive offices)

(516) 677-0200

(Registrant’s telephone number, including area code)

Not applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

VECO

The NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 2.02 Results of Operations and Financial Condition.

On November 6, 2023, Veeco Instruments Inc. issued a press release announcing its financial results for the quarter ended September 30, 2023. In connection with the release and the related conference call, Veeco posted a presentation relating to its third quarter 2023 financial results on its website (www.veeco.com). Copies of the press release and presentation are furnished as Exhibit 99.1 and Exhibit 99.2 to this report.

Item 9.01 Financial Statements and Exhibits.

(d)   Exhibits.

EXHIBIT INDEX

Exhibit

  

Description

99.1

Press release issued by Veeco dated November 6, 2023

99.2

Veeco Q3 2023 Conference Call Presentation November 6, 2023

104

Cover Page Interactive Data File (formatted as inline XBRL).

Limitation on Incorporation by Reference

In accordance with general instruction B.2 of Form 8-K, the information in this report, including exhibits, is furnished pursuant to Items 2.02 and 9.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, nor shall this information or exhibits be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

November 6, 2023

VEECO INSTRUMENTS INC.

By:

/s/ Kirk Mackey

Name: Kirk Mackey

Title: Vice President, General Counsel

2

EXHIBIT 99.1

Graphic

VEECO REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS

Third Quarter 2023 Highlights:

Revenue of $177.4 million, compared with $171.9 million in the same period last year
GAAP net income of $24.6 million, or $0.42 per diluted share, compared with $15.0 million, or $0.27 per diluted share in the same period last year
Non-GAAP net income of $31.0 million, or $0.53 per diluted share, compared with $26.0 million, or $0.45 per diluted share in the same period last year

Plainview, N.Y., November 6, 2023 -- Veeco Instruments Inc. (Nasdaq: VECO) today announced financial results for its third quarter ended September 30, 2023. Results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and are also reported adjusting for certain items (“Non-GAAP”). A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release.  

U.S. Dollars in millions, except per share data

GAAP Results

 

Q3 '23

Q3 '22

Revenue

$

177.4

$

171.9

Net income

$

24.6

$

15.0

Diluted earnings per share

$

0.42

$

0.27

Non-GAAP Results

 

Q3 '23

Q3 '22

Operating income

$

32.7

$

28.4

Net income

$

31.0

$

26.0

Diluted earnings per share

$

0.53

$

0.45

“Veeco reported another quarter of strong top and bottom-line results, both above the high-end of our guidance” commented Bill Miller, Ph.D., Veeco’s Chief Executive Officer. “In addition, our strategic initiative to grow in the Semiconductor market continues to gain traction. Veeco had several key business wins during the quarter, and we recently shipped our first Nanosecond Annealing system to a Tier 1 logic customer for evaluation. We view this as an important milestone in expanding laser annealing into a broad range of new Semiconductor applications.”

1


Guidance and Outlook

The following guidance is provided for Veeco’s fourth quarter 2023:

Revenue is expected in the range of $155 million to $175 million
GAAP diluted earnings per share are expected in the range of $0.22 to $0.33
Non-GAAP diluted earnings per share are expected in the range of $0.35 to $0.45

Conference Call Information

A conference call reviewing these results has been scheduled for today, November 6, 2023 starting at 5:00pm ET. To join the call, dial 1-877-407-8029 (toll-free) or 1-201-689-8029. Participants may also access a live webcast of the call by visiting the investor relations section of Veeco's website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website that evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.

About Veeco

Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our laser annealing, ion beam, chemical vapor deposition (CVD), metal organic chemical vapor deposition (MOCVD), single wafer etch & clean and lithography technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com.

Forward-looking Statements

This press release contains “forward-looking statements”, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, as amended, that are based on management’s expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements include, but are not limited to, those regarding anticipated growth and trends in our businesses and markets, industry outlooks and demand drivers, our investment and growth strategies, our development of new products and technologies, our business outlook for current and future periods, our ongoing transformation initiative and the effects thereof on our operations and financial results; and other statements that are not historical facts. These statements and their underlying assumptions are subject to risks and uncertainties and are not guarantees of future performance. Factors that could cause actual results to differ materially from those expressed or implied by such statements include, without limitation: the level of demand for our products; global economic and industry conditions; global trade issues, including the ongoing trade disputes between the U.S. and China, and changes in trade and export license policies; our dependency on third-party suppliers and outsourcing partners; the timing of customer orders; our ability to develop, deliver and support new products and technologies; our ability to expand our current markets, increase market share and develop new markets; the concentrated nature of our customer base; our ability to obtain and protect intellectual property rights in key technologies; the effects of regional or global health epidemics, including the effects of the COVID-19 pandemic on the Company’s operations and on those of our customers and suppliers; our ability to achieve the objectives of operational and strategic initiatives and attract, motivate and retain key employees; the variability of results among products and end-markets, and our ability to accurately forecast future results, market conditions, and customer requirements; the impact of our indebtedness, including our convertible senior notes and our capped call transactions; and other risks and uncertainties described in our SEC filings on Forms 10-K, 10-Q and 8-K, and from time-to-time in our other SEC reports. All forward-looking statements speak only to management’s expectations, estimates, projections and assumptions as of the date of this press release or, in the case of any document referenced herein or incorporated by reference, the date of that document. The Company does not undertake any obligation to update or publicly revise any forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.

-financial tables attached-

Veeco Contacts:

Investors:Anthony Pappone (516) 500-8798apappone@veeco.com

Media:Kevin Long (516) 714-3978klong@veeco.com

2


Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Statements of Operations

(in thousands, except per share amounts)
(unaudited)

Three months ended September 30,

Nine months ended September 30,

 

    

2023

    

2022

    

2023

    

2022

 

Net sales

 

$

177,366

 

$

171,913

 

$

492,511

 

$

492,338

Cost of sales

 

100,489

 

101,962

 

286,107

 

292,109

Gross profit

 

76,877

 

69,951

 

206,404

 

200,229

Operating expenses, net:

Research and development

 

28,817

 

27,104

 

83,762

 

77,237

Selling, general, and administrative

 

22,814

 

22,144

 

69,263

 

67,987

Amortization of intangible assets

 

2,123

 

2,505

 

6,358

 

7,514

Other operating expense (income), net

 

860

 

634

 

1,264

 

587

Total operating expenses, net

 

54,614

 

52,387

 

160,647

 

153,325

Operating income

 

22,263

 

17,564

 

45,757

 

46,904

Interest expense, net

 

247

 

(2,315)

 

(1,187)

 

(7,753)

Other income (expense), net

(97,091)

Income (loss) before income taxes

 

22,510

 

15,249

 

(52,521)

 

39,151

Income tax expense (benefit)

 

(2,064)

 

208

 

(516)

 

1,125

Net income (loss)

 

$

24,574

 

$

15,041

 

$

(52,005)

 

$

38,026

Income (loss) per common share:

Basic

 

$

0.44

 

$

0.30

 

$

(0.98)

 

$

0.76

Diluted

 

$

0.42

 

$

0.27

 

$

(0.98)

 

$

0.70

Weighted average number of shares:

Basic

 

55,352

 

49,887

 

52,978

 

49,831

Diluted

 

59,636

 

65,151

 

52,978

 

65,090

3


Veeco Instruments Inc. and Subsidiaries
Condensed Consolidated Balance Sheets

(in thousands)

September 30,

December 31,

    

2023

    

2022

(unaudited)

Assets

Current assets:

Cash and cash equivalents

$

156,419

$

154,925

Restricted cash

 

378

 

547

Short-term investments

 

130,117

 

147,488

Accounts receivable, net

 

122,393

 

124,221

Contract assets

 

29,475

 

16,507

Inventories

 

252,120

 

206,908

Prepaid expenses and other current assets

 

29,898

 

18,305

Total current assets

 

720,800

 

668,901

Property, plant and equipment, net

 

118,213

 

107,281

Operating lease right-of-use assets

24,960

 

26,467

Intangible assets, net

 

46,069

 

23,887

Goodwill

 

214,964

 

181,943

Deferred income taxes

 

118,069

 

116,349

Other assets

 

3,158

 

3,355

Total assets

$

1,246,233

$

1,128,183

Liabilities and stockholders’ equity

Current liabilities:

Accounts payable

$

62,985

$

52,049

Accrued expenses and other current liabilities

 

65,599

 

56,031

Customer deposits and deferred revenue

 

138,723

 

127,223

Income taxes payable

 

479

 

2,432

Current portion of long-term debt

20,169

Total current liabilities

 

267,786

 

257,904

Deferred income taxes

 

6,865

 

1,285

Long-term debt

 

274,646

 

254,491

Long-term operating lease liabilities

32,154

 

33,581

Other liabilities

 

20,302

 

3,098

Total liabilities

 

601,753

 

550,359

Total stockholders’ equity

 

644,480

 

577,824

Total liabilities and stockholders’ equity

$

1,246,233

$

1,128,183

Note on Reconciliation Tables

The below tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

4


Reconciliation of GAAP to Non-GAAP Financial Data (Q3 2023)

(in thousands)
(unaudited)

Non-GAAP Adjustments

 

Share-Based

 

Three months ended September 30, 2023

    

GAAP

    

Compensation

    

Amortization

    

Other

    

Non-GAAP

 

Net sales

$

177,366

$

177,366

 

Gross profit

 

76,877

 

1,556

 

 

78,433

Gross margin

 

43.3

%

 

44.2

%

Operating expenses

 

54,614

 

(5,864)

(2,123)

(911)

45,716

Operating income

 

22,263

 

7,420

2,123

 

911

^

32,717

Net income

 

24,574

 

7,420

 

2,123

 

(3,077)

^

31,040


^

- See table below for additional details.

Other Non-GAAP Adjustments (Q3 2023)

(in thousands)
(unaudited)

Three months ended September 30, 2023

    

Changes in contingent consideration

$

818

Acquisition related

93

Subtotal

911

Non-cash interest expense

 

311

Non-GAAP tax adjustment *

 

(4,299)

Total Other

$

(3,077)


*

- The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

Net Income per Common Share (Q3 2023)

(in thousands, except per share amounts)
(unaudited)

Three months ended September 30, 2023

GAAP

Non-GAAP

Numerator:

Net income

    

$

24,574

    

$

31,040

Interest expense associated with 2025 and 2027 Convertible Senior Notes

 

513

 

 

466

Net income available to common shareholders

$

25,087

$

31,506

Denominator:

Basic weighted average shares outstanding

55,352

55,352

Effect of potentially dilutive share-based awards

1,391

1,391

Dilutive effect of 2025 Convertible Senior Notes

1,104

1,104

Dilutive effect of 2027 Convertible Senior Notes (1)

 

1,789

 

 

1,355

Diluted weighted average shares outstanding

59,636

59,202

Net income per common share:

Basic

$

0.44

$

0.56

Diluted

$

0.42

$

0.53


(1)  -  The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, an effective conversion price of $18.46 is used when determining incremental shares to add to the dilutive share count. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, an effective conversion price of $13.98 is used when determining incremental shares to add to the dilutive share count.

5


Reconciliation of GAAP to Non-GAAP Financial Data (Q3 2022)

(in thousands, except per share amounts)
(unaudited)

Non-GAAP Adjustments

 

Share-based

Three months ended September 30, 2022

    

GAAP

    

Compensation

    

Amortization

    

Other

    

Non-GAAP

Net sales

$

171,913

$

171,913

Gross profit

 

69,951

 

1,195

 

1,102

 

72,248

Gross margin

 

40.7

%  

42.0

%

Operating expenses

 

52,387

 

(5,015)

(2,505)

(981)

43,886

Operating income

 

17,564

 

6,210

2,505

 

2,083

^

28,362

Net income

 

15,041

 

6,210

 

2,505

 

2,252

^

26,008


^

- See table below for additional details.

Other Non-GAAP Adjustments (Q3 2022)

(in thousands)
(unaudited)

Three months ended September 30, 2022

Transition expenses related to San Jose expansion project

$

1,936

Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting

147

Subtotal

2,083

Non-cash interest expense

 

242

Non-GAAP tax adjustment *

 

(73)

Total Other

$

2,252


*

- The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

Net Income per Common Share (Q3 2022)

(in thousands, except per share amounts)
(unaudited)

Three months ended September 30, 2022

GAAP

Non-GAAP

Numerator:

Net income

    

$

15,041

    

$

26,008

Interest expense associated with convertible notes

 

2,549

 

 

2,467

Net income available to common shareholders

$

17,590

$

28,475

Denominator:

Basic weighted average shares outstanding

49,887

49,887

Effect of potentially dilutive share-based awards

801

801

Dilutive effect of 2023 Convertible Senior Notes

504

Dilutive effect of 2025 Convertible Senior Notes

5,521

5,521

Dilutive effect of 2027 Convertible Senior Notes (1)

 

8,942

 

 

6,771

Diluted weighted average shares outstanding

65,151

63,484

Net income per common share:

Basic

$

0.30

$

0.52

Diluted

$

0.27

$

0.45


(1)    - The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, an effective conversion price of $18.46 is used when determining incremental shares to add to the dilutive share count. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, an effective conversion price of $13.98 is used when determining incremental shares to add to the dilutive share count.

6


Reconciliation of GAAP Net Income to Non-GAAP Operating Income (Q3 2023 and 2022)

(in thousands)
(unaudited)

    

Three months ended

    

Three months ended

September 30, 2023

September 30, 2022

GAAP Net income

$

24,574

$

15,041

Share-based compensation

 

7,420

 

6,210

Amortization

 

2,123

 

2,505

Transition expenses related to San Jose expansion project

 

 

1,936

Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting

 

 

147

Changes in contingent consideration

818

Acquisition related

 

93

 

Interest (income) expense, net

 

(247)

 

2,315

Income tax expense (benefit)

 

(2,064)

 

208

Non-GAAP Operating income

$

32,717

$

28,362

Reconciliation of GAAP to Non-GAAP Financial Data (Q4 2023)

(in millions, except per share amounts)

(unaudited)

Non-GAAP Adjustments

 

Guidance for the three months ending

Share-based

 

December 31, 2023

GAAP

Compensation

Amortization

   Other    

Non-GAAP

 

Net sales

    

$

155

    

-

    

$

175

    

    

    

    

$

155

    

-

    

$

175

Gross profit

 

66

 

-

 

76

 

1

 

 

 

67

 

-

 

77

Gross margin

 

42%

-

 

43%

 

 

 

43%

-

 

44%

Operating expenses

53

 

-

 

55

(6)

(2)

45

 

-

 

47

Operating income

14

-

21

7

2

23

-

30

Net income

$

13

 

-

$

20

 

7

 

2

(2)

$

20

 

-

$

27

Income per diluted common share

$

0.22

 

-

$

0.33

 

  

 

  

 

  

$

0.35

 

-

$

0.45

Income per Diluted Common Share (Q4 2023)

(in millions, except per share amounts)
(unaudited)

Guidance for the three months ending December 31, 2023

GAAP

Non-GAAP

Numerator:

Net income

    

$

13

    

-

    

$

20

    

$

20

    

-

    

$

27

Interest expense associated with convertible notes

 

 

 

 

 

 

 

Net income available to common shareholders

$

13

-

$

20

$

20

-

$

27

Denominator:

Basic weighted average shares outstanding

56

56

56

56

Effect of potentially dilutive share-based awards

1

 

1

1

 

1

Dilutive effect of 2025 Convertible Senior Notes

 

1

 

1

 

1

Dilutive effect of 2027 Convertible Senior Notes (1)

 

2

 

2

 

 

1

 

1

Diluted weighted average shares outstanding

59

60

60

60

Net income per common share:

Income per diluted common share

$

0.22

-

$

0.33

$

0.35

-

$

0.45


(1)    - The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, an effective conversion price of $18.46 is used when determining incremental shares to add to the dilutive share count. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, an effective conversion price of $13.98 is used when determining incremental shares to add to the dilutive share count.

7


Reconciliation of GAAP Net Income to Non-GAAP Operating Income (Q4 2023)

(in millions)
(unaudited)

Guidance for the three months ending December 31, 2023

    

    

    

GAAP Net income

$

13

 

-

$

20

Share-based compensation

 

7

 

-

 

7

Amortization

 

2

 

-

 

2

Income tax expense (benefit)

1

-

1

Non-GAAP Operating income

$

23

 

-

$

30

Note: Amounts may not calculate precisely due to rounding.

8


GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 1 Veeco Instruments Q3 2023 Financial Results Conference Call - November 6th, 2023

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 2 Safe Harbor This presentation contains “forward-looking statements”, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, as amended, that are based on management’s expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements include, but are not limited to, those regarding anticipated growth and trends in our businesses and markets, industry outlooks and demand drivers, our investment and growth strategies, our development of new products and technologies, our business outlook for current and future periods, our ongoing transformation initiative and the effects thereof on our operations and financial results; and other statements that are not historical facts. These statements and their underlying assumptions are subject to risks and uncertainties and are not guarantees of future performance. Factors that could cause actual results to differ materially from those expressed or implied by such statements include, without limitation: global trade issues, including the ongoing trade disputes between the U.S. and China, and changes in trade and export license policies; the level of demand for our products; global economic and industry conditions; our dependency on third-party suppliers and outsourcing partners; the timing of customer orders; our ability to develop, deliver and support new products and technologies; our ability to expand our current markets, increase market share and develop new markets; the concentrated nature of our customer base; our ability to obtain and protect intellectual property rights in key technologies; the effects of regional or global health epidemics, including the effects of the COVID-19 pandemic on the Company’s operations and on those of our customers and suppliers; our ability to achieve the objectives of operational and strategic initiatives and attract, motivate and retain key employees; the variability of results among products and end-markets, and our ability to accurately forecast future results, market conditions, and customer requirements; the impact of our indebtedness, including our convertible senior notes and our capped call transactions; and other risks and uncertainties described in our SEC filings on Forms 10-K, 10-Q and 8-K, and from time-to-time in our other SEC reports. All forward-looking statements speak only to management’s expectations, estimates, projections and assumptions as of the date of this presentation. The Company does not undertake any obligation to update or publicly revise any forward-looking statements to reflect events, circumstances or changes in expectations after the date of this presentation.

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 3 Bill Miller, Ph.D. CEO Overview and Business Update

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 4 Q3 Financial & Business Highlights $177M $33M 0.53¢ Revenue Non-GAAP Operating Income Diluted Non-GAAP EPS • Top and bottom-line results above high-end of guidance • Semiconductor revenue remains elevated • Sequential growth in Data Storage • Shipped LSA systems to Tier 1 Logic and Memory customers • New application wins: • LSA in automotive • LDD IBD for EUV pellicles • Further progress with new NSA and IBD products Robust results driven by Semiconductor strength and sequential growth in Data Storage LSA – Laser Spike Annealing NSA – Nanosecond Spike Annealing LDD – Low Defect Density IBD - Ion Beam Deposition EUV – Extreme Ultraviolet

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 5 Market Update Core Technologies Laser Annealing Ion Beam Lithography Wet Epitaxy Processing Ion Beam Data Storage core technologies providing significant value for advanced node semiconductor applications. Expect year-over-year growth in 2023. Compound Semiconductor opportunity driven by demand for epitaxy equipment for power electronics and photonics applications Semiconductor strength driven by broad demand for LSA systems. LSA adoption for new applications expected to drive future growth. Wet Processing

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 6 Veeco Technologies for Artificial Intelligence Advanced Packaging Current PTOR • Wet Processing for micro-bump flux clean • Lithography for Cu bumps Additional Future Opportunities • Wet Processing for temporary bond clean GPU Current PTOR • Laser-Spike Annealing (LSA) • IBD for EUV mask blanks Additional Future Opportunities • Nanosecond Annealing (NSA) • IBD for low resistivity metals High-Bandwidth Memory (HBM) DRAM Current PTOR • Laser-Spike Annealing (LSA) Additional Future Opportunities • Nanosecond Annealing (NSA) • IBD for low resistivity metals Illustration of typical AI chip PTOR = Production Tool of Record TSV = Through Silicon Via GPU = Graphics Processing Unit HBM – High-Bandwidth Memory

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 7 Nanosecond Annealing Opportunity Enabling technology with strong customer pull • Shipped 1st NSA500TM eval system to Tier 1 logic customer • Solidifies Veeco’s leadership in advanced laser annealing technology and helps drive the Semi industry roadmap • Opportunity to expand SAM in Logic and Memory • Low thermal budget steps like Backside Power Delivery and Contact Anneal for advanced nodes • Material Modification steps like void removal, recrystallization and grain growth • Planning 2 nd eval shipment to Tier 1 customer in Q4 & initial HVM orders in late 2024 or 2025 Temperature (°C) Time SAM – Served Available Market HVM – High Volume Manufacturing NSA (nanosecond) 1000 2000 LSA (sub millisecond) 100 NSA LSA Heating Depth 10nm-100nm ~100 μm Very shallow Heats full wafer Lamp based (sub second) Lamp based Full wafer Illustration of Wafer Cross Section

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 8 Ion Beam Deposition– Advanced Node Semi Opportunity Adapting IBD technology for advanced node wafer level semiconductor applications • Leveraging decades of experience and core IBD technology in Semiconductor market • Innovative technology addresses gaps with traditional technologies • Lower resistance metals essential for device speed and performance • Promising Tier 1 customer data displaying significant advantages vs PVD • On track to ship two evaluations to Tier 1 customers PVD IBD Illustration of grain size and distribution Uniformly oriented large grains = lowest resistivity Non-uniform, randomly oriented grains of small size PVD – Physical Vapor Deposition

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 9 John Kiernan CFO Financial Review

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 10 Q3 2023 Revenue by Market & Region 56% 14% 11% 19% Revenue by Market Revenue by Region Scientific & Other Semiconductor Compound Semiconductor Data Storage 29% 23% 15% 33% EMEA APAC China United States $177M Revenue Trend ($M) Q3 22 Q2 23 Q3 23 Semiconductor 100 106 98 Compound Semi 28 24 26 Data Storage 28 14 34 Scientific & Other 16 17 20 Total 172 162 177 Amounts may not calculate precisely due to rounding. ROW is negligible

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 11 Q3 2023 Operating Results In millions (except per share amounts) GAAP Non-GAAP Q2 23 Q3 23 Q2 23 Q3 23 Revenue $161.6 $177.4 $161.6 $177.4 Gross Profit 67.5 76.9 69.1 78.4 Gross Margin 41.8% 43.3% 42.7% 44.2% Operating Expenses 53.8 54.6 44.8 45.7 Operating Income 13.7 22.3 24.3 32.7 Net Income (Loss) ($85.3)* $24.6 20.6 31.0 Diluted Earnings (Loss) Per Share ($1.61)* $0.42 $0.36 $0.53 Diluted Shares 52.9 59.6 61.2 59.2 *Net loss of $85.3 million or $1.61 per share was principally from a $97 million loss on extinguishment from refinancing a portion of our Convertible Notes. Amounts may not calculate precisely due to rounding. A reconciliation of GAAP to Non-GAAP financial measures can be found in the backup section of this presentation.

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 12 Balance Sheet and Cash Flow Highlights $ millions Q2 23 Q3 23 Cash & Short-Term Investments 287 287 Accounts Receivable 130 122 Inventories 244 252 Accounts Payable 63 63 Long-Term Debt Including Current Portion 274 275 Cash Flow from Operations 11 7 DSO (days) 72 62 DIO (days) 225 222 DPO (days) 61 57 Capital Expenditures 4 6 Amounts may not calculate precisely due to rounding. A reconciliation of GAAP to Non-GAAP financial measures can be found in the backup section of this presentation.

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 13 2023 Guidance A reconciliation of GAAP to Non-GAAP financial measures can be found in the backup section of this presentation. Q4 2023 Updated 2023 Revenue Outlook • Revenue from $630 - $670 million to $648 - $668 million Raising 2023 Non-GAAP EPS Outlook • Non-GAAP EPS from between $1.30 - $1.50 to $1.55 - $1.65 GAAP Non-GAAP Revenue $155M - $175M $155M - $175M Gross Margin 42% - 43% 43% - 44% Operating Expenses $53M - $55M $45M - $47M Net Income / (Loss) $13M - $20M $20M - $27M Diluted Earnings / (Loss) Per Share $0.22 - $0.33 $0.35 - $0.45

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 14 CEO Closing Remarks

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 15 Thank You Q&A

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 16 Backup and Financial Tables

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 17 Historical Revenue by End-Market $M 2020 2021 2022 2023 Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Q4 FY Q1 Q2 Q3 Semiconductor 37.4 37.5 33.6 57.4 165.9 51.6 53.7 76.3 65.4 247.1 77.6 97.5 100.4 93.8 369.4 93.1 106.3 98.2 Compound Semi 18.4 17.8 26.6 45.2 107.9 24.8 24.2 23.3 34.7 107.0 37.1 31.1 28.1 24.9 121.2 21.2 24.1 25.7 Data Storage 38.9 28.3 36.9 19.2 123.3 41.0 52.0 39.3 36.5 168.8 21.6 21.5 27.7 16.7 87.5 21.5 13.9 34.0 Scientific & Other 9.8 15.1 15.0 17.1 57.0 16.4 16.4 11.4 16.3 60.5 20.1 13.8 15.7 18.4 68.0 17.7 17.4 19.6 Total 104.5 98.6 112.1 138.9 454.2 133.7 146.3 150.2 153.0 583.3 156.4 164.0 171.9 153.8 646.1 153.5 161.6 177.4 Amounts may not calculate precisely due to rounding.

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 18 Note on Reconciliation Tables These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, incremental transaction-related compensation, and certain integration costs. These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors' operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating Income, which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 19 Supplemental Information—GAAP to Non-GAAP Reconciliation Amounts may not calculate precisely due to rounding. $ millions Q2 23 Q3 23 Net sales $161.6 $177.4 GAAP gross profit 67.5 76.9 GAAP gross margin 41.8% 43.3% Add: Share-based comp 1.6 1.5 Non-GAAP gross profit $69.1 $78.4 Non-GAAP gross margin 42.7% 44.2% In millions Q2 23 Q3 23 GAAP Net income (loss) ($85.3) $24.6 Add: Share-based comp 7.9 7.4 Add: Amortization 2.1 2.1 Add: Transition expenses related to San Jose expansion project - - Add: Changes in contingent consideration 0.3 0.8 Add: Acquisition related 0.2 0.1 Add: Other (income) expense, net 97.1 - Add: Interest expense (income) 0.6 (0.3) Add: Tax expense (benefit) 1.3 (2.1) Non-GAAP operating income $24.3 $32.7 $ millions, except per share amounts Q2 23 Q3 23 GAAP Basic weighted average shares 52.9 55.4 GAAP Diluted weighted average shares 52.9 59.6 GAAP Basic EPS ($1.61) $0.44 GAAP Diluted EPS ($1.61) $0.42 GAAP Net income (loss) ($85.3) $24.6 Add: Share-based comp 7.9 7.4 Add: Amortization 2.1 2.1 Add: Transition expenses related to San Jose expansion project - - Add: Changes in contingent consideration 0.3 0.8 Add: Acquisition related 0.2 0.1 Add: Non-cash interest expense 0.3 0.3 Add: Other (income) expense, net 97.1 - Add: Tax adjustment from GAAP to Non-GAAP (2.1) (4.3) Non-GAAP net income 20.6 31.0 Non-GAAP basic EPS $0.39 $0.56 Non-GAAP diluted EPS $0.36 $0.53 Non-GAAP basic weighted average shares 52.9 55.4 Non-GAAP diluted weighted average shares 61.2 59.2 In millions Q2 23 Q3 23 GAAP operating expenses $53.8 $54.6 Share-based compensation (6.4) (5.9) Amortization (2.1) (2.1) Other (0.5) (0.9) Non-GAAP operating expenses $44.8 $45.7

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 20 $ millions Non-GAAP Adjustments GAAP Share-Based Compensation Amortization Other Non-GAAP Net Sales $177.4 $177.4 Gross Profit 76.9 1.5 — — 78.4 Gross Margin 43.3% 44.2% Operating Expenses $54.6 (5.9) (2.1) (0.9) $45.7 Operating Income $22.3 7.4 2.1 0.9 $32.7 Net Income (loss) $24.6 7.4 2.1 (3.1) $31.0 Q3 2023 Actual: GAAP to Non-GAAP Reconciliation Amounts may not calculate precisely due to rounding. Income per Diluted Common Share GAAP Non-GAAP Net Income $24.6 $31.0 Add: Interest on Convertible Senior Notes 0.5 0.5 Net income available to common shareholders 25.1 31.5 Basic weighted average common shares 55.4 55.4 Add: Dilutive effect of share-based awards 1.4 1.4 Add: Dilutive effect of 2025 Convertible Senior Notes 1.1 1.1 Add: Dilutive effect of 2027 Convertible Senior Notes 1.8 1.4 Diluted weighted average common shares 59.6 59.2 Basic income per common share $0.44 $0.56 Diluted income per common share $0.42 $0.53 Other Non-GAAP Adjustments Changes in contingent consideration $0.8 Acquisition related 0.1 Subtotal 0.9 Non-cash Interest Expense 0.3 Non-GAAP tax adjustment (4.3) Total Other ($3.1)

GRAPHIC

Q3 2023 Financial Results Conference Call Copyright © 2023 Veeco Instruments Inc. All Rights Reserved. 21 Reconciliation of GAAP to non-GAAP Financial Data Non-GAAP Adjustments GAAP Share-Based Compensation Amortization Other Non-GAAP Net Sales $155–$175 $155–$175 Gross Profit 66–76 1 — — 67–77 Gross Margin 42%–43% 43%–44% Operating Expenses $53–$55 (6) (2) — $45–$47 Operating Income $14–$21 7 2 — $23–$30 Net Income $13–$20 7 2 (2) $20–$27 Income per Diluted Share $0.22–$0.33 $0.35–$0.45 Q4 2023 Guidance ($ millions, except per share amounts) Amounts may not calculate precisely due to rounding. Income per Diluted Common Share GAAP Non-GAAP Net Income $13–$20 $20–$27 Add: Interest on Convertible Senior Notes 0-0 0-0 Net income available to common shareholders 13-20 20-27 Basic weighted average common shares 56 56 Add: Dilutive effect of share-based awards 1-1 1-1 Add: Dilutive effect of 2025 Convertible Senior Notes 0-1 1-1 Add: Dilutive effect of 2027 Convertible Senior Notes 2-2 1-1 Diluted weighted average common shares 59-60 60-60 Income per diluted common share $0.22-$0.33 $0.35-$0.45 Reconciliation of GAAP Net Income to non-GAAP Operating Income GAAP Net Income $13–$20 Share-Based Compensation 7 Amortization 2 Income tax expense 1 Non-GAAP Operating Income $23–$30

v3.23.3
Document and Entity Information
Nov. 06, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Nov. 06, 2023
Entity Registrant Name VEECO INSTRUMENTS INC.
Entity Incorporation, State or Country Code DE
Entity File Number 0-16244
Entity Tax Identification Number 11-2989601
Entity Address, Address Line One Terminal Drive
Entity Address, City or Town Plainview
Entity Address, State or Province NY
Entity Address, Postal Zip Code 11803
City Area Code 516
Local Phone Number 677-0200
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol VECO
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0000103145
Amendment Flag false

Veeco Instruments Inc DE (NASDAQ:VECO)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Veeco Instruments Inc DE Charts.
Veeco Instruments Inc DE (NASDAQ:VECO)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Veeco Instruments Inc DE Charts.